Lna Santé S.A (LNA) | Stock Overview & Key Data
Lna Santé S.A. | Mid-cap | Healthcare
Lna Santé S.A. | Mid-cap | Healthcare
Lna Santé S.A Performance Comparison
Stock Range
Today's Range
Low: €27.30
High: €28.20
on August 4, 2025
52 Week Range
Low: €20.60
High: €28.80
on April 7, 2025
on July 31, 2025
All-Time High: €68.60 on June 12, 2017
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Market Cap
€292.5M
EPS
2.13
P/E Ratio (TTM)
13.29
Forward P/E
10.33
P/B Ratio
0.92
PEG Ratio
10.33
Div. Yield
2.50%
ROE
7.25%
Beta
0.678
Debt to Equity
270.87
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
8.43%
Profit Margin
2.71%
Returns and Earnings
Return on Assets (TTM)
2.80%
Return on Equity (TTM)
7.25%
EBITDA
€152.4M
Net Income (TTM)
€21.8M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€78.89
Quarterly Revenue Growth (YoY)
12.00%
Quarterly Earnings Growth (YoY)
-17.60%
Dividend Information
Last 12-Month Dividend
€0.65
Current Dividend Yield
2.50%
3-Year Average Dividend Yield
2.25%
3-Year Average Annual Dividend
€0.58
3-Year Total Dividends
€1.75
Ex-Dividend Date
July 8, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Lna Santé S.A LNA | 292.46M Mid-cap | 4.43% | 10.12% | 22.51% | 28.64% | 17.67% | 13.43% | -14.11% | -44.29% |
| Emeis S.A EMEIS | 2.22B Large-cap | 18.55% | 24.34% | 12.16% | 106.62% | 125.99% | 36.44% | -99.12% | -99.80% |
| Orpea ORP | 1.96B Mid-cap | 18.55% | 24.34% | 12.16% | 106.62% | 125.99% | 36.44% | -99.12% | -99.80% |
| Clariene SE CLARI | 1.62B Large-cap | -10.69% | -14.97% | 13.59% | 96.02% | 106.05% | 146.11% | -42.09% | -42.09% |
| Ramsay Générale de GDS | 1.16B Large-cap | -2.34% | -4.13% | 7.51% | -2.34% | -18.36% | -31.92% | -51.17% | -38.89% |
| EssilorLuxottica EL | 117.73B Large-cap | 2.24% | 8.68% | -0.85% | -3.30% | 9.01% | 22.50% | 59.41% | 133.58% |
Ownership & Short Interest
Insider Ownership
54.30%
Institutional Ownership
9.16%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
3K
Average 90-Day Volume
2K
Lna Santé S.A Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Lna Santé S.A would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is LNA's 52-week high and low?
- In the last 52 weeks, Lna Santé S.A reached a high of €28.80 (on July 31, 2025) and a low of €20.60 (on April 7, 2025).
- What is the market cap and P/E ratio for LNA?
- Curious about Lna Santé S.A's size and valuation? Its market capitalization stands at 292.46M. When it comes to valuation, the P/E ratio (trailing twelve months) is 13.29, and the forward P/E (looking ahead) is 10.33.
- Does LNA pay dividends? If so, what's the yield?
- Yes, Lna Santé S.A is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 2.50%, and the company has paid an average of €0.58 per share annually over the past 3 years.
- Who are Lna Santé S.A's main competitors or similar companies to consider before investing?
When looking at Lna Santé S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Emeis S.A
EMEIS2.22B Healthcare Medical Care Facilities 36.44% -99.12% Orpea
ORP1.96B Healthcare Medical Care Facilities 36.44% -99.12% Clariene SE
CLARI1.62B Healthcare Medical Care Facilities 146.11% -42.09% Ramsay Générale de
GDS1.16B Healthcare Medical Care Facilities -31.92% -51.17% EssilorLuxottica
EL117.73B Healthcare Medical Instruments & Supplies 22.50% 59.41% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Lna Santé S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Lna Santé S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 7.25%, the Debt to Equity ratio from the most recent quarter is 270.87, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for LNA?
- Looking at Lna Santé S.A's growth, its revenue over the trailing twelve months (TTM) was €807M. Compared to the same quarter last year (YoY), quarterly revenue grew by 12.00%, and quarterly earnings saw a YoY growth of -17.60%.
- How much of LNA stock is held by insiders and institutions?
- Wondering who owns Lna Santé S.A stock? Company insiders (like executives and directors) hold about 54.30% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 9.16%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.